You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
吉林敖東(000623.SZ):子公司延邊藥業獲得6箇中藥配方顆粒上市備案憑證
格隆匯 10-26 09:01

格隆匯10月26日丨吉林敖東(000623.SZ)公佈,近日,公司控股子公司吉林敖東延邊藥業股份有限公司(簡稱“延邊藥業”)獲得6個《中藥配方顆粒上市備案憑證》。產品名稱分別為“青皮(個青皮)配方顆粒”、“酒黃連(黃連)配方顆粒”、“荊芥配方顆粒”、“醋青皮(四花青皮)配方顆粒”、“炒山楂(山裏紅)配方顆粒”、“酒川牛膝配方顆粒”。

延邊藥業作為公司核心層企業,在中藥領域具有一定優勢,截至該公吿刊登之日已累計獲得208個《中藥配方顆粒上市備案憑證》,對公司拓展中藥配方顆粒業務具有重要意義,為公司持續發展創造了有利條件,進一步增強了企業的核心競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account